Article Text

Download PDFPDF
Can I treat this pregnant patient with botulinum toxin?
  1. Catharine Sarah Pearce
  1. Cardiff University School of Medicine, Cochrane Medical Education Centre, Cardiff, UK
  1. Correspondence to Catharine Sarah Pearce, 9 Baring Crescent, Exeter, Devon EX1 1TL, UK; pearcecs{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Botulinum toxin type A (BoNT-A) is used to treat dystonia. The commonest form, cervical dystonia, is more common in women; since many are still of childbearing age,1 some women on botulinum toxin treatment inevitably will either be planning to become pregnant or may wish to be treated while pregnant. The use of BoNT-A for chronic migraine—a female-predominant disorder—will make botulinum treatment an increasingly common issue for women,2 leaving aside the use of BoNT-A in a cosmetic setting. To inform discussions with patients, clinicians need to understand the known …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Ralph Gregory, Poole, UK.

Linked Articles

  • Editors' choice
    Phil Smith Geraint N Fuller

Other content recommended for you